High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review

Clinical Therapeutics

Volumn 31, Issue PART. 2, 2009, Pages 2371-2378

  Mahtani, Reshma L ^a   Stein, Alisha ^b   Vogel, Charles L ^a  

^a Boca Raton Comprehensive Cancer Center   (United States)

^b Cancer Research Network Inc   (United States)

Author keywords

estrogen treatment; hormonal therapy; metastatic breast cancer; salvage treatment

Indexed keywords

ACETYLSALICYLIC ACID; AROMATASE INHIBITOR; DIETHYLSTILBESTROL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGED; ARTHRALGIA; ARTICLE; BLOATING; BREAST CANCER; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESTROGEN THERAPY; FATIGUE; FEMALE; FLUID RETENTION; HEPATORENAL SYNDROME; HUMAN; LETHARGY; LIVER DYSFUNCTION; MASTALGIA; MEDICAL RECORD REVIEW; NAUSEA; PRURITUS; SIDE EFFECT; VAGINA BLEEDING; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; POSTMENOPAUSE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 74549119748     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.11.002     Document Type: Article

References (20)

1. Haddow A., Watkinson J.M., Paterson E., and Koller P.C. Influence of synthetic oestrogens upon advanced malignant disease. BMJ. 2 (1944) 393-398
2. Kennedy B.J., Kelly R.M., White G., and Nathanson I.T. Surgery as an adjunct to hormone therapy of breast cancer. Cancer. 10 (1957) 1055-1075
3. Stoll B.A. Responses to repeated doses of stilboesterol. BMJ. 3 (1973) 446-450
4. Cole M.P., Jones C.T., and Todd I.D. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer. 25 (1971) 270-275
5. Ingle J.N., Ahmann D.L., Green S.J., et al. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med. 304 (1981) 16-21
6. Ingle J.N. Estrogen as therapy for breast cancer. Breast Cancer Res. 4 (2002) 133-136
7. Gockerman J.P., Spremulli E.N., Raney M., and Logan T. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: A Southeastern Cancer Study Group trial. Cancer Treat Rep. 70 (1986) 1199-1203
8. Peethambaram P.P., Ingle J.N., Suman V.J., et al. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with advanced breast cancer. An updated analysis. Breast Cancer Res Treat. 54 (1999) 117-122
9. Hayes D.F., Henderson I.C., and Shapiro C.L. Treatment of metastatic breast cancer: Present and future prospects. Semin Oncol. 22 Suppl 5 (1995) 5-19 discussion
10. Hayes D.F., Henderson I.C., and Shapiro C.L. Treatment of metastatic breast cancer: Present and future prospects. Semin Oncol. 22 Suppl 5 (1995) 19-21
11. National Cancer Institute Common Terminology Criteria for Adverse Events, v3.0 (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf Accessed October 15, 2009
12. Ellis M.J., Gao F., Dehdashti F., et al. Lower-dose vs highdose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study. JAMA. 302 (2009) 774-780
13. Lønning P.E., Taylor P.D., Anker G., et al. High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat. 67 (2001) 111-116
14. Massidda B., Mascia V., Broccia G., et al. Estrogen therapy of advanced breast cancer [in Italian]. Minerva Med. 68 (1977) 2509-2516
15. Beex L., Pieters G., Smals A., et al. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer. Cancer Treat Rep. 65 (1981) 179-185
16. Agrawal A., Robertson J.F., and Cheung K.L. Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents. World J Surg Oncol. 4 (2006) 44
17. Hayes D.F., Van Zyl J.A., Hacking A., et al. Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol. 13 (1995) 2556-2566
18. Masamura S., Santner S.J., Heitjan D.F., and Santen R.J. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab. 80 (1995) 2918-2925
19. Yao K., Lee E.S., Bentrem D.J., et al. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Clin Cancer Res. 6 (2000) 2028-2036
20. Song R.X., Mor G., Naftolin F., et al. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst. 93 (2001) 1714-1723